Further weakness as Genscript Biotech drops 16 percent this week, taking three-year losses to 62 percent - Simply Wall St
GNNSF Stock | USD 1.25 0.01 0.79% |
Roughly 61% of Genscript Biotech's investor base is looking to short. The analysis of overall sentiment of trading Genscript Biotech pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Genscript Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Genscript Biotech stock news signals to limit their universe of possible portfolio assets.
Genscript Biotech pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genscript daily returns and investor perception about the current price of Genscript Biotech as well as its diversification or hedging effects on your existing portfolios.
Genscript |
Further weakness as Genscript Biotech drops 16 percent this week, taking three-year losses to 62 Simply Wall St
Read at news.google.com
Genscript Biotech Fundamental Analysis
We analyze Genscript Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genscript Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genscript Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Genscript Biotech is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Genscript Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genscript Biotech pink sheet to make a market-neutral strategy. Peer analysis of Genscript Biotech could also be used in its relative valuation, which is a method of valuing Genscript Biotech by comparing valuation metrics with similar companies.
Peers
Genscript Biotech Related Equities
ICCC | ImmuCell | 6.03 | ||||
TLPPF | Telix Pharmaceuticals | 5.40 | ||||
MRUS | Merus BV | 3.33 | ||||
KROS | Keros Therapeutics | 2.17 | ||||
IVBXF | Innovent Biologics | 0.62 | ||||
NUVL | Nuvalent | 0.05 | ||||
NUVB | Nuvation Bio | 0.76 | ||||
INBX | Inhibrx | 0.88 | ||||
NXTC | NextCure | 0.92 | ||||
ZNTL | Zentalis Pharmaceuticals | 1.28 | ||||
LCTX | Lineage Cell | 1.92 | ||||
KRON | Kronos Bio | 2.00 | ||||
CNTB | Connect Biopharma | 2.61 | ||||
OVID | Ovid Therapeutics | 2.83 | ||||
CVKD | Cadrenal Therapeutics, | 3.45 | ||||
CRNX | Crinetics Pharmaceuticals | 3.52 | ||||
ONTTF | Oxford Nanopore | 3.92 | ||||
LYEL | Lyell Immunopharma | 11.84 |
Complementary Tools for Genscript Pink Sheet analysis
When running Genscript Biotech's price analysis, check to measure Genscript Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genscript Biotech is operating at the current time. Most of Genscript Biotech's value examination focuses on studying past and present price action to predict the probability of Genscript Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genscript Biotech's price. Additionally, you may evaluate how the addition of Genscript Biotech to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |